Advances in anti-angiogenic agents for ovarian cancer treatment: The role of trebananib (AMG 386)

Published 2015 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Advances in anti-angiogenic agents for ovarian cancer treatment: The role of trebananib (AMG 386)
Authors
Keywords
AMG 386, Trebananib, Angiopoietin, Anti-angiogenesis, Ovarian cancer, Targeted therapy, Peptibody
Journal
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Volume 94, Issue 3, Pages 302-310
Publisher
Elsevier BV
Online
2015-03-04
DOI
10.1016/j.critrevonc.2015.02.001

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.